Follow-up study of liver metastasis from breast cancer treated by proton beam therapy

  • Authors:
    • Nobuyoshi Fukumitsu
    • Toshiyuki Okumura
    • Haruko Numajiri
    • Daichi Takizawa
    • Kayoko Ohnishi
    • Masashi Mizumoto
    • Teruhito Aihara
    • Hitoshi Ishikawa
    • Koji Tsuboi
    • Hideyuki Sakurai
  • View Affiliations

  • Published online on: June 1, 2017     https://doi.org/10.3892/mco.2017.1283
  • Pages: 56-60
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Liver metastasis from breast cancer (LMBC) is an incurable, fatal disease with a very poor prognosis. Although various local treatments have been applied, their clinical utility has not been established. The purpose of this study was to investigate the safety and effectiveness of proton beam therapy (PBT) for the treatment of patients with LMGC. A total of 8 female patients (aged 38‑63 years) with LMBC who received PBT between 2002 and 2012 were retrospectively reviewed. Patients who had tumors confined to the liver were investigated, whereas patients with extrahepatic tumors were excluded. A total of 5 patients had solitary tumors and 3 had multiple tumors. The total irradiation dose was 66‑72.6 Gray equivalent [Gy relative biological effectiveness (RBE)] and 2 patients received concurrent chemotherapy or hormone therapy. The overall and progression‑free survival (OS and PFS) rates, local control (LC) rate and adverse effects were investigated. All the patients completed treatment without interruption and late adverse effects of grade >3 were not observed. The OS rate was 88/73/58%, the PFS rate was 50/25/0% and the LC rate was 86/86/86% at 1/3/5 years, respectively. Thus, PBT is a safe treatment and the OS and PFS rates are comparable to those with other local treatments. PBT may be considered as an effective local treatment option for the treatment of LMBC patients.
View Figures
View References

Related Articles

Journal Cover

July 2017
Volume 7 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Fukumitsu, N., Okumura, T., Numajiri, H., Takizawa, D., Ohnishi, K., Mizumoto, M. ... Sakurai, H. (2017). Follow-up study of liver metastasis from breast cancer treated by proton beam therapy. Molecular and Clinical Oncology, 7, 56-60. https://doi.org/10.3892/mco.2017.1283
MLA
Fukumitsu, N., Okumura, T., Numajiri, H., Takizawa, D., Ohnishi, K., Mizumoto, M., Aihara, T., Ishikawa, H., Tsuboi, K., Sakurai, H."Follow-up study of liver metastasis from breast cancer treated by proton beam therapy". Molecular and Clinical Oncology 7.1 (2017): 56-60.
Chicago
Fukumitsu, N., Okumura, T., Numajiri, H., Takizawa, D., Ohnishi, K., Mizumoto, M., Aihara, T., Ishikawa, H., Tsuboi, K., Sakurai, H."Follow-up study of liver metastasis from breast cancer treated by proton beam therapy". Molecular and Clinical Oncology 7, no. 1 (2017): 56-60. https://doi.org/10.3892/mco.2017.1283